Elevai Labs, Inc. Common Stock Form 3 Elevai Labs / Lichti Braeden ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Braeden Lichti

(Last)

(First)

(Middle)

650 WEST GEORGIA STREET #3200

(Street)

VANCOUVER

V6B 4P7

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/28/2023

3. Issuer Name and Ticker or Trading Symbol
Elevai Labs Inc. [ ELAB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,967,965	I	By BWL Investments Ltd.⁽¹⁾
Common Stock	828,000	I	By BWL Holdings Ltd.⁽²⁾
Common Stock	828,000	I	By NorthStrive Fund II LP⁽³⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. As of December 28, 2023, BWL Investments Ltd., a company owned and controlled by Braeden Lichti, owned 1,967,965 shares of common stock of the Issuer.

2. As of December 28, 2023, BWL Holdings Ltd., a company owned and controlled by Braeden Lichti, owned 828,000 shares of common stock of the Issuer.

3. As of December 28, 2023, NorthStrive Fund II LP., a company owned and controlled by Braeden Lichti, owned 828,000 shares of common stock of the Issuer.

	/s/ Braeden Lichti	02/01/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Elevai Labs, Inc. Common Stock (ELAB) Form 3Elevai Labs / Lichti Braeden ownership change